about
Use of the dermoscope as a smartphone close-up lens and LED annular macro ring flash.The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases.Pemphigus: a complex T cell-dependent autoimmune disorder leading to acantholysis.Exacerbation of pemphigus after influenza vaccination.A glass of red wine to keep vascular disease at bay, but what about pemphigus vulgaris?Angiokeratoma: decision-making aid for the diagnosis of Fabry disease.Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris.Acquired epidermodysplasia verruciformis: a comprehensive review and a proposal for treatment.Glycaemic index, glycaemic load and risk of cutaneous melanoma in a population-based, case-control study.Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.The impact of fever/hyperthermia in the diagnosis of Fabry: A retrospective analysis.Sex Differences in Axial and Limb Distribution of Melanocytic Naevi.Psoriatic Pseudobalanitis Circinata as a Post-Viral Koebner Phenomenon.A possible role for CD8+ T lymphocytes in the cell-mediated pathogenesis of pemphigus vulgaris.Dermoscopy of melanocytic lesions in patients affected by oculocutaneous albinism: a case series.Early-onset basal cell carcinoma in a case of Ivemark syndrome.Cysteinyl-leukotriene D4 induced IL-1 beta expression and release in rat vascular smooth muscle cells.Ocular mucous membrane pemphigoid after Lyell syndrome: occasional finding or predisposing event?Small lymphocytic lymphoma in a patient with Fabry disease.Rethinking the role of tumour necrosis factor-alpha in ultraviolet (UV) B-induced immunosuppression: altered immune response in UV-irradiated TNFR1R2 gene-targeted mutant mice.Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases.Lupus vulgaris developing at the site of misdiagnosed scrofuloderma.Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis."Eczema-like" leishmaniasis in an HIV patient.Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.Skin toxicity from glyphosate-surfactant formulation.Herpes simplex virus infection in pemphigus vulgaris: clinical and immunological considerations.Increased serum Interleukin-18 in the active phase of Henoch-Schönlein purpura.Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years.Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients.Mutation identification of Fabry disease in families with other lysosomal storage disorders.Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.Modelling the resource implications of managing adults with Fabry disease in Italy.Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene.Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.Early miscarriage during Sweet's syndrome: uncommon, but probably not coincidental.Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosisRANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b
P50
Q33449227-9C4E0C49-E49B-4CEC-BDD5-1F731C2D448EQ35751178-1946531F-25ED-4159-88E1-718C6D5FDC62Q37039690-3EE879C9-33E5-403F-8993-5358889171C2Q37235674-BEDFC8EC-6EA6-4E94-8F4A-7BF22A6361A4Q37855948-1EFB6BCA-C8FB-4AC7-A217-23345D3F1807Q37997470-646F3E35-CE9A-4C1B-883B-096738CA58A3Q38058868-191E00AB-3ACA-486C-9929-15F74B5EDAA4Q38084334-DD26E808-CD3C-4389-93D9-73D8801D8905Q38961856-69150AB6-B62F-4B42-971A-8879C97192AFQ39123775-222AE5B1-27DC-49D2-89D5-AE73AABA4AFDQ40109719-22879ABF-D54E-4E86-AD73-8B33A4C8C943Q40613561-4F5EF4BF-BFA7-478F-BA09-A03124CFF83EQ41494297-0172F6F8-993E-445F-ADC9-6721758F5D75Q41952852-6F750A04-1219-4430-9E83-BA7431052819Q42440759-DCBFD7EA-F31B-4E87-916E-620EAF9F231FQ42478565-12057DDA-42FF-41A1-90E9-CB9DCF1AEAEBQ42482204-C777FBD3-91E7-4E1B-B0EC-7EB59D5AFDE5Q42499477-72EC1614-E2C0-4568-B806-93C6190A8CB3Q43530901-8C04C4C7-9487-4632-9E0E-36A81D512C9BQ43612561-10410114-0377-4234-9440-D943F59B4B74Q43960825-CF4E89E6-5CCB-4CB1-956B-ADD3805B16C8Q44407950-0819AB46-F6A7-4F62-8F86-83273CD6EEEAQ44557332-329B54D2-ED6D-4E5A-A930-37F1DDDD5F5BQ44559441-20BD11CD-6733-40ED-9138-E6789907685FQ44824480-5F2280F8-4673-433E-82C2-A5856503E4D1Q45055019-6B6276BA-F3ED-495E-A2F2-FDCEA48E31E9Q45394213-75FE584B-22D2-41BB-9997-22729989737BQ46440240-7E7DC445-C48C-4F07-AD16-0A0CDC1619D1Q46527693-49A439D3-8AE3-4635-9200-2B271B371CAFQ46528022-BB68FB66-4770-4C14-B565-147F2756E9ABQ46918747-B3F69503-8CB0-42A5-8C79-1C739D524CD5Q50795517-DF09A08F-508F-4C63-888D-EF9776964F1FQ50849312-0856236B-8C89-4B62-8DF3-B7DB73C1FD03Q51158499-28BCDDF0-BF31-4FCB-B21D-09E2F696870FQ51471726-953338F7-68E7-4295-B027-0CB38C9AF8DAQ53816009-29A535C7-3D7F-404D-81DB-37B364E49E1BQ53843470-1B61153B-69DF-41A6-8E53-EA0FFB07C569Q54762197-AB26CF89-F117-4D3B-B35E-6692219B2D7BQ59389230-51538803-5430-447B-8E13-DF59E44DCACDQ59389234-D6349920-4520-4E1D-B3B6-2E64045B6C89
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudio Feliciani
@ast
Claudio Feliciani
@en
Claudio Feliciani
@es
Claudio Feliciani
@nl
type
label
Claudio Feliciani
@ast
Claudio Feliciani
@en
Claudio Feliciani
@es
Claudio Feliciani
@nl
prefLabel
Claudio Feliciani
@ast
Claudio Feliciani
@en
Claudio Feliciani
@es
Claudio Feliciani
@nl
P106
P21
P31
P496
0000-0003-0883-3210